Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial

Peer Review reports

Original Submission
24 Nov 2020	Submitted	Original manuscript
30 Nov 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
1 Dec 2020	Editorially accepted
10 Dec 2020	Article published	10.1186/s13063-020-04944-5

Back to article page